Titan Net Current Assets as percentage of Total Assets from 2010 to 2024

TTNP Stock  USD 7.16  0.22  2.98%   
Check Titan Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Titan main balance sheet or income statement drivers, such as Depreciation And Amortization of 270.8 K, Total Revenue of 49.4 K or Other Operating Expenses of 13.2 M, as well as many exotic indicators such as Price To Sales Ratio of 3.8 K, Dividend Yield of 0.0015 or Operating Cycle of 291. Titan financial statements analysis is a perfect complement when working with Titan Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Titan Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Titan Pharmaceuticals Technical models . Check out the analysis of Titan Pharmaceuticals Correlation against competitors.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.

About Titan Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Titan Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Titan Pharmaceuticals investors use historical funamental indicators, such as Titan Pharmaceuticals's Net Current Assets as percentage of Total Assets, to determine how well the company is positioned to perform in the future. Although Titan Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Titan Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Titan Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Titan Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Titan Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. The company was incorporated in 1992 and is based in South San Francisco, California. Titan Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.

Currently Active Assets on Macroaxis

When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock:
Check out the analysis of Titan Pharmaceuticals Correlation against competitors.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Titan Stock analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.20)
Revenue Per Share
0.409
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.61)
Return On Equity
(1.06)
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.